Abstract
Breast cancer is the most common cancer in women and breast cancer liver metastasis
may be associated with poor outcomes. Emerging locoregional therapies can be given
in outpatient settings or with short hospital stays, to provide local control, support
quality of life, preserve liver function, and potentially prolong survival. This review
discusses retrospective studies suggesting potential benefits of locoregional treatment
of breast cancer liver metastasis. Future prospective studies are needed to demonstrate
efficacy and optimize patient selection.
Keywords
breast cancer - locoregional - hepatic metastasis - ablation - chemoembolization -
radioembolization
